ORIGINAL ARTICLE Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer Jasmine Foo, PhD,* Juliann Chmielecki, PhD,† William Pao

First Page		Document Content
Date: 2012-10-16 11:34:15 Chemistry Organic chemistry Clinical medicine Amines Quinazolines Lung cancer Ethers Erlotinib Pfizer Gefitinib Epidermal growth factor receptor T790M		ORIGINAL ARTICLE Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer Jasmine Foo, PhD,* Juliann Chmielecki, PhD,† William Pao Add to Reading List Source URL: michorlab.dfci.harvard.edu Download Document from Source Website File Size: 1,60 MB Share Document on Facebook

	Chemistry_BS_Biochemistry.pdf DocID: 1xUCR - View Document
	Chemistry_BS_Environmental Chemistry.pdf DocID: 1xUxX - View Document
	Chemistry, BA "DBEFNJD.BQ General DocID: 1xU5A - View Document
	The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with "Activators" by Robert A. Nelson Science has bestowed many wonderments upon us, but the Return-On-Investment is quickly diminishing (th DocID: 1xTUH - View Document
	Chemistry_BS_General BS to MS Accelerated Pathway.pdf DocID: 1xTpY - View Document